Canada markets open in 5 hours 39 minutes

Hikma Pharmaceuticals PLC (HIK.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
1,968.00+8.00 (+0.41%)
As of 08:32AM BST. Market open.
Currency in GBp

Valuation Measures4

Market Cap (intraday) 4.35B
Enterprise Value 5.12B
Trailing P/E 28.92
Forward P/E 12.29
PEG Ratio (5 yr expected) 2.38
Price/Sales (ttm)1.90
Price/Book (mrq)2.48
Enterprise Value/Revenue 1.78
Enterprise Value/EBITDA 9.27

Trading Information

Stock Price History

Beta (5Y Monthly) 0.44
52-Week Change 35.43%
S&P500 52-Week Change 324.49%
52 Week High 32,222.00
52 Week Low 31,711.00
50-Day Moving Average 31,882.09
200-Day Moving Average 31,932.91

Share Statistics

Avg Vol (3 month) 3624.97k
Avg Vol (10 day) 3402.59k
Shares Outstanding 5221.88M
Implied Shares Outstanding 6221.88M
Float 8154.66M
% Held by Insiders 130.65%
% Held by Institutions 138.79%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.57
Forward Annual Dividend Yield 42.93%
Trailing Annual Dividend Rate 30.72
Trailing Annual Dividend Yield 30.04%
5 Year Average Dividend Yield 41.99
Payout Ratio 472.75%
Dividend Date 3N/A
Ex-Dividend Date 4Mar 21, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 6.61%
Operating Margin (ttm)21.41%

Management Effectiveness

Return on Assets (ttm)8.46%
Return on Equity (ttm)8.81%

Income Statement

Revenue (ttm)2.88B
Revenue Per Share (ttm)13.02
Quarterly Revenue Growth (yoy)11.00%
Gross Profit (ttm)N/A
EBITDA 791M
Net Income Avi to Common (ttm)190M
Diluted EPS (ttm)0.68
Quarterly Earnings Growth (yoy)293.30%

Balance Sheet

Total Cash (mrq)229M
Total Cash Per Share (mrq)1.04
Total Debt (mrq)1.19B
Total Debt/Equity (mrq)53.92%
Current Ratio (mrq)1.57
Book Value Per Share (mrq)9.94

Cash Flow Statement

Operating Cash Flow (ttm)608M
Levered Free Cash Flow (ttm)445.25M